tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 252 are a BUY (93.68%), 16 are a HOLD (5.95%), 1 are a SELL (0.37%).
Analyst Steven Seedhouse, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 42.32% that have a potential upside of 67.18% achieved within 347 days.
Steven Seedhouse’s has documented 475 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ETNB, 89bio at 08-Nov-2024.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for NGM (NGM BIOPHARMACEUTICALS) at 10/17/2022. The price target of $4 was fulfilled within 3 days with a profit of $0.59 (17.3%) receiving and performance score of 57.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$205
$22.5 (12.33%)
3 years 7 months 12 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
3 years 7 months 14 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
$7.5 (4.11%)
$194
3 years 10 months 13 days ago
(04-Feb-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
$166
$-16.5 (-9.04%)
$175
3 years 10 months 13 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Buy
$155
3 years 11 months 10 days ago
(07-Jan-2021)
7/7 (100%)
$36.79 (31.12%)
395
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
